Health
Study identifies therapeutic targets for most lethal pancreatic cancer – Drug Target Review
The detailed analysis of adenosquamous cancer of the pancreas (ASCP) suggested FGFR and RORC were two promising therapeutic targets.
Posted: 15 September 2020 | Hannah Balfour (Drug Target Review) | No comments yet
The detailed analysis of adenosquamous cancer of the pancreas (ASCP) suggested FGFR and RORC were two promising therapeutic targets.
Using preclinical models, researchers have identified two promising therapeutic targets for the most aggressive and lethal form of pancreatic cancer, adenosquamous cancer of the pancreas (ASCP).
The team of researchers led by Mayo Clinic and the Translational Genomics Research Inst…
-
Noosa News14 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News12 hours agoQueensland Drug and Alcohol Court provides sentencing options – Proctor
-
Business14 hours agoSolid superannuation gains continue to roll in
-
General12 hours agoSingapore’s world-first sustainable flights tax will see some Australians pay more to travel